<DOC>
	<DOCNO>NCT01425788</DOCNO>
	<brief_summary>The purpose trial investigate tolerability Osiris Phleum pratense use 2 simplified up-dosing schedule compare up-dosing schedule use current practice .</brief_summary>
	<brief_title>Comparison Different Up-dosing Schedules With Osiris Phleum Pratense</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<criteria>Written inform consent obtain enter trial Male female &gt; /= 18 year visit 1 A clinically relevant history grass pollen induce allergic rhinoconjunctivitis ( moderate severe ) receive symptomatic treatment grass pollen season 2010 2011 Positive skin prick test response ( wheal diameter &gt; /= 3mm ) Phleum pratense Positive specific IgE Phleum pratense ( &gt; /= 0,70KUL / class 2 ) Female subject childbearing potential must negative pregnancy test willing practice appropriate contraceptive method Visit 4 Subjects willing able comply trial protocol regimen Subjects include another protocol ( treatment intervention and/or investigational medicine product ) participate another clinical trial within 30 day prior visit 1 A clinically relevant history symptomatic seasonal allergic rhinoconjunctivitis cause allergen ( e.g . hazel , alder , birch , ash ) subject expose 30day treatment period . A clinically relevant medical history symptomatic perennial allergy allergen ( ) subject regularly expose ( e.g . cat , house dust mite ) . Known sensitization ( history positive SPT ) food allergens oral allergy syndrome Uncontrolled asthma ( accordance GINA guideline ) within last 12 month FEV &lt; 60 % predict within last 12 month Severe asthma exacerbation ( ) within last 12 month A clinically relevant chronic disease ( &gt; /= 3 month ) ( e.g fibrosis , malignancy , type 1 diabetes mellitus , malabsorption malnutrition , renal hepatic insufficiency ) Malignancy systemic disease affect immune system ( e.g . autoimmune disease , immune complex disease immune deficiency disease ) Inflammatory condition oral cavity severe symptom oral lichen planus ulceration severe oral mycosis dental extraction randomisation Medical history recurrent urticaria atopic dermatitis last 2 year Currently receive treatment prevent initiation SIT ( e.g . tricyclic antidepressant , mono amine oxidase inhibitor ( MAOIs ) catecholOmethyl transferase inhibitor ( COMT inhibitor ) ) History allergy , hypersensitivity , intolerance excipients investigational medicinal product Being immediate family investigator trial staff , define investigator 's / staff 's spouse , parent , grandparent , child grandchild History drug induce ( incl . immunotherapy ) facial angioedema ( include experience Quincke oedema ) family ( parent sibling ) history hereditary angioedema Anticipated use prohibit medication within specified time window define protocol Previous treatment immunotherapy grass pollen one month within last 5 year Any clinically significant condition situation , condition study , opinion investigator would interfere trial evaluation optimal participation History anaphylaxis cardio respiratory symptom ( e.g . food allergy , drug idiopathic reaction )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Grass pollen induce allergic rhinoconjunctivitis</keyword>
</DOC>